Description Module

Description Module

The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.

Description Module path is as follows:

Study -> Protocol Section -> Description Module

Description Module


Ignite Creation Date: 2025-12-26 @ 11:00 AM
Ignite Modification Date: 2025-12-26 @ 11:00 AM
NCT ID: NCT01504906
Brief Summary: The purpose of this study is to assess the effect of Cyclosporine on the blood levels of Ticagrelor.
Detailed Description: A Single-Center,Open-Label,Randomized,3-Treatment,3-Period Cross-Over Study to Investigate the Potential Effect of Cyclosporine on the Pharmacokinetics, Safety, and Tolerability of Ticagrelor and the Effect of Ticagrelor on the Pharmacokinetics, Safety, and Tolerability of Cyclosporine.
Study: NCT01504906
Study Brief:
Protocol Section: NCT01504906